Submitted by FNUOvviyaa on
![](https://assets.medpagetoday.net/media/images/99xxx/99238.jpg)
...
In standard-risk COVID-19 patients, nirmatrelvir/ritonavir (Paxlovid) failed to show a significant reduction in hospitalizations or death, with 5 events in the treatment arm and 10 in the placebo arm, Pfizer announced. Results were similar in a vaccinated subgroup...
...
Vaccinating everyone against monkeypox is likely unrealistic. (The Atlantic)...
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -